Betta Pharmaceuticals Co Ltd Sz300558 Established In 2003 In Hangzhouchinais One Of The Leading Chinese Pharmaceutical Companies Dedicated To Develop And Commercialize Innovative Oncology Products To Meet High Unmet Medical Needswith Over 1 300 Employees In Hangzhou And Beijingchinabetta S Development Capabilities Range From Small Molecule And Biologics Discoveryclinical Developmentregistrationmanufacturingsales And Marketingbetta S Leading Product Aeicotinibconmanaathe First Innovative Oncology Product Developed And Commercially Launched By A Chinese Pharmaceutical Company Aeis The No 1 Selling Targeted Therapy Treating Non Small Cell Lung Cancer Patients Carrying Egfr Mutations In Chinahaving Achieved 1 25 Billion Rmb Annual Sales In 2018Betta Currently Has Three Programs Under Late Stage Clinical Developmentthree Programs Under Proof Of Concept Clinical Developmenttwo Programs Under Ind Review By The Nmpa And Close To Twenty Programs Under Pre Clinical Developmentbetta Has Set Up Joint Ventures With Amgen Inc Amgnand Tyrogenex Incand Is The Majority Shareholder Of Xcovery Llcfor Additional Informationplease Visit Http En Bettapharma Com
